Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05028751
Title A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Kronos Bio
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of California Los Angeles (UCLA) Recruiting Los Angeles California 990095 United States Details
The Blood and Marrow Transplant Group of Georgia Recruiting Atlanta Georgia 30342 United States Details
University of Chicago Medical Center Recruiting Chicago Illinois 60637 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Oregon Health and Science University Recruiting Portland Oregon 97239 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Completed Dallas Texas 75246 United States Details
Froedtert Hospital Recruiting Milwaukee Wisconsin 53226 United States Details
Hospital San Pedro de Alcantara Not yet recruiting Cáceres 10001 Spain Details
*Shaded cells indicate that there was no data available from for the field